melatonin has been researched along with Uterine Neoplasms in 6 studies
Uterine Neoplasms: Tumors or cancer of the UTERUS.
Excerpt | Relevance | Reference |
---|---|---|
"In previous studies a tumor-size dependent decline of the circadian amplitude of serum melatonin was found in primary unoperated breast cancer patients, which was not due to changes of the hepatic metabolism of melatonin since its main peripheral metabolite, 6-sulphatoxymelatonin (aMT6s), showed similar serum levels." | 7.69 | Nocturnal urinary 6-sulphatoxymelatonin excretion is decreased in primary breast cancer patients compared to age-matched controls and shows negative correlation with tumor-size. ( Bartsch, C; Bartsch, H; Franz, H; Karenovics, A; Mecke, D; Peiker, G, 1997) |
"Highly differentiated endometrial adenocarcinoma is described in which the cells of the APUD-system (apudocytes) producing melatonin, noradrenaline and chorionic gonadotropin are detected histochemically and immunohistochemically." | 7.67 | [Polyfunctional endometrial adenocarcinoma producing melatonin, noradrenaline and chorionic gonadotropin]. ( Kvetnoĭ, IM; Rodkina, RA; Stoliarova, ES, 1985) |
"Treatment with melatonin increased the distribution of sub-G1 phase and increased DNA condensation in ELT3 cells." | 5.56 | Melatonin activates cell death programs for the suppression of uterine leiomyoma cell proliferation. ( Chen, HY; Chiang, YF; Hong, HC; Hsia, SM; Hsu, SP; Huang, KC; Huang, TC; Lin, PH; Tung, YT, 2020) |
"The melatonin hypothesis states that excess exposure to environmental light may contribute to breast cancer risks via impaired pineal secretion of melatonin." | 3.70 | Does winter darkness in the Artic protect against cancer? The melatonin hypothesis revisited. ( Erren, TC; Piekarski, C, 1999) |
"Melatonin inhibited thymidine incorporation into human choriocarcinoma JEG-3 cells at physiological and pharmacological concentrations in the present study." | 3.70 | Inhibition of malignant trophoblastic cell proliferation in vitro and in vivo by melatonin. ( Mei, L; Pang, SF; Shiu, SY; Wong, JT; Xi, SC; Xu, JN; Yao, KM, 2000) |
"In previous studies a tumor-size dependent decline of the circadian amplitude of serum melatonin was found in primary unoperated breast cancer patients, which was not due to changes of the hepatic metabolism of melatonin since its main peripheral metabolite, 6-sulphatoxymelatonin (aMT6s), showed similar serum levels." | 3.69 | Nocturnal urinary 6-sulphatoxymelatonin excretion is decreased in primary breast cancer patients compared to age-matched controls and shows negative correlation with tumor-size. ( Bartsch, C; Bartsch, H; Franz, H; Karenovics, A; Mecke, D; Peiker, G, 1997) |
"Highly differentiated endometrial adenocarcinoma is described in which the cells of the APUD-system (apudocytes) producing melatonin, noradrenaline and chorionic gonadotropin are detected histochemically and immunohistochemically." | 3.67 | [Polyfunctional endometrial adenocarcinoma producing melatonin, noradrenaline and chorionic gonadotropin]. ( Kvetnoĭ, IM; Rodkina, RA; Stoliarova, ES, 1985) |
"Treatment with melatonin increased the distribution of sub-G1 phase and increased DNA condensation in ELT3 cells." | 1.56 | Melatonin activates cell death programs for the suppression of uterine leiomyoma cell proliferation. ( Chen, HY; Chiang, YF; Hong, HC; Hsia, SM; Hsu, SP; Huang, KC; Huang, TC; Lin, PH; Tung, YT, 2020) |
"Melatonin has protective roles in normal cells and cytotoxic actions in cancer cells, with effects involving autophagy and nuclear factor (erythroid-derived 2)-like 2 (Nrf2) transcription factor pathways." | 1.51 | Melatonin: The smart molecule that differentially modulates autophagy in tumor and normal placental cells. ( Bienvenue-Pariseault, J; Sagrillo-Fagundes, L; Vaillancourt, C, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Lin, PH | 1 |
Tung, YT | 1 |
Chen, HY | 1 |
Chiang, YF | 1 |
Hong, HC | 1 |
Huang, KC | 1 |
Hsu, SP | 1 |
Huang, TC | 1 |
Hsia, SM | 1 |
Sagrillo-Fagundes, L | 1 |
Bienvenue-Pariseault, J | 1 |
Vaillancourt, C | 1 |
Bartsch, C | 1 |
Bartsch, H | 1 |
Karenovics, A | 1 |
Franz, H | 1 |
Peiker, G | 1 |
Mecke, D | 1 |
Erren, TC | 1 |
Piekarski, C | 1 |
Shiu, SY | 1 |
Xi, SC | 1 |
Xu, JN | 1 |
Mei, L | 1 |
Pang, SF | 1 |
Yao, KM | 1 |
Wong, JT | 1 |
Rodkina, RA | 1 |
Kvetnoĭ, IM | 1 |
Stoliarova, ES | 1 |
6 other studies available for melatonin and Uterine Neoplasms
Article | Year |
---|---|
Melatonin activates cell death programs for the suppression of uterine leiomyoma cell proliferation.
Topics: Animals; Apoptosis; Autophagy; Cell Line; Cell Line, Tumor; Cell Proliferation; Female; Humans; Leio | 2020 |
Melatonin: The smart molecule that differentially modulates autophagy in tumor and normal placental cells.
Topics: Apoptosis; Autophagy; Cell Line, Tumor; Choriocarcinoma; Female; Humans; Melatonin; Neoplasm Protein | 2019 |
Nocturnal urinary 6-sulphatoxymelatonin excretion is decreased in primary breast cancer patients compared to age-matched controls and shows negative correlation with tumor-size.
Topics: Breast Neoplasms; Female; Fibroadenoma; Fibrocystic Breast Disease; Humans; Leiomyoma; Melatonin; Mi | 1997 |
Does winter darkness in the Artic protect against cancer? The melatonin hypothesis revisited.
Topics: Alaska; Arctic Regions; Breast Neoplasms; Canada; Darkness; Female; Greenland; Humans; Male; Melaton | 1999 |
Inhibition of malignant trophoblastic cell proliferation in vitro and in vivo by melatonin.
Topics: Animals; Cell Division; Cell Survival; Choriocarcinoma; Female; Gene Expression Regulation, Neoplast | 2000 |
[Polyfunctional endometrial adenocarcinoma producing melatonin, noradrenaline and chorionic gonadotropin].
Topics: Adenocarcinoma; Chorionic Gonadotropin; Female; Humans; Melatonin; Middle Aged; Norepinephrine; Uter | 1985 |